Next came Xarelto (rivaroxaban) by Johnson & Johnson, which was approved in 2011.
None of these three blood thinners--Pradaxa, Xarelto, and Eliquis--currently have an approved antidote for a patient experiencing a trauma-induced bleeding event or needing emergency surgery.